Inpatient Drug Rehab – What Works Best in Treatment

When it comes to inpatient drug rehab and addiction treatment for the most part people can’t seem the think all that needs to be dealt with in a rehab program. One of the greatest challenges in helping drug or alcohol addicts recover is ensuring that they follow through with the discharge plan laid out as part of the treatment process.

Many mental health professionals or addiction counselors feel addicts should have access to-and participate in-follow-up care, counseling and support after their release from inpatient rehabilitation programs. Which is true to a degree, however if the rehabilitation and recovery program is complete and a thorough discharge plan is in place, follow up “treatment” should be a non issue for the most part.

Long term rehabilitation programs that handle physical addiction, mental emotional issues and provide life skill training that enables the addict to overcome the obstacles in life that would cause relapse. This does not come about in disease based treatment modality, as the problem is never really overcome in theory, it is continually “treated” therefore always exists for the addict. If a problem continues to exist and can never be resolved, of course it would only be managed and require continual care or treatment.

Using an approach that enables someone to improve conditions to the degree any problem could be solved permanently would negate the need for continual follow-up care. Continuing to improve conditions however can be part of the therapeutic process since nothing ever stays the same. It is continually improving or declining, with that continual therapeutic methods taken to improve the conditions of someone’s life would be a very positive move.

Millions of dollars have been spent studying the most positive approaches to treatment, follow-up care and addiction in general. Unfortunately most of this has been centered around a treatment modality whose philosophy is based on having a disease that you can never overcome. The mantra used with this approach preaches “relapse is part of recovery” which would in fact require continual treatment, as the addiction can never really be overcome.

There are high ranking Schools of Medicine which have Behavioral Pharmacology Research Units, like Johns Hopkins University, which study what programs are most successful in helping encourage people coming out of inpatient treatment centers to enroll in after-care that will support their recovery. It should be noted these studies are often funded through pharmaceutical companies, which of course would promote drugs as part of the recovery process. Prescribing drugs to deal with life’s issues on a daily basis further suppresses the abilities of anyone to deal with these problems head on and handle them effectively.

Currently there are 320 stimulus-funded research grants totaling nearly $157.4 million that Johns Hopkins has garnered since Congress passed the American Recovery and Revitalization Act of 2009 (informally known by the acronym ARRA), bestowing the National Institutes of Health and the National Science Foundation with $12.4 billion in additional money to underwrite research grants by September 2010.

It would be fortunate for many if these funds and research were focused on programs that offer an ends to a means, or complete recovery in treatment. Inpatient drug rehab programs that offer rehabilitation methods to handle physical addiction, underlying mental emotional issues, and teach life skills provide much higher chances of success at permanent recovery from substance abuse and addiction. Drug programs like this improve the abilities of the addict and better enable one to overcome obstacles and diminish disabilities like dependence on drugs or alcohol.

Next Post

Leukemia - Treatment Breakthroughs For Chronic Lymphocytic Leukemia

Recently released news from a U.S. pharmaceutical company stunned the market when they revealed that they had trialed a new drug that may help in the fight against chronic lymphocytic leukemia (CLL). About one month ago “Ibrutinib,” a new orally taken drug that is said to be different from traditional […]

You May Like